Article Text

other Versions

PDF
A missense mutation in PTCH2 underlies dominantly inherited NBCCS in a Chinese family
  1. Zhipeng Fan
  1. Molecular Laboratory for Gene Therapy, Capital Medical University School of Stomatology, China
    1. Jingyuan Li
    1. Molecular Laboratory for Gene Therapy, Capital Medical University School of Stomatology, China
      1. Juan Du
      1. Molecular Laboratory for Gene Therapy, Capital Medical University School of Stomatology, China
        1. Honglai Zhang
        1. Department of Biologic and Materials Sciences, University of Michigan, United States
          1. Yan Shen
          1. Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, China
            1. Cun-Yu Wang
            1. Department of Biologic and Materials Sciences, University of Michigan, United States
              1. Songlin Wang (songlinwang{at}dentist.org.cn)
              1. Molecular Laboratory for Gene Therapy, Capital Medical University School of Stomatology, China

                Abstract

                Background: Nevoid basal cell carcinoma syndrome (NBCCS) is a pleiotropic, autosomal dominant disease. Growing evidence suggests that the disorder may result from mutations in genes of the Sonic hedgehog (Shh) signalling pathway. Objective: The present study aimed to investigate the pathogenic gene in a Chinese Han NBCCS family.

                Methods: Mapping and mutation screening were used to investigate the candidate genes SHH, PTCH, PTCH2, and SMO. A GLI1 reporter gene and cell growth curve were used to examine functional consequences of the detected mutant.

                Results: One novel mutation, a G-to-A transition (2157G>A) in exon 15 of the PTCH2 gene, was identified in this NBCCS family by direct sequencing and was detected with the AvaI restriction enzyme. The mutation was not observed in normal family members or in 520 controls. The mutation led to an R719Q amino acid substitution in an extracellular loop of the PTCH2 protein. Functional studies revealed that the R719Q mutation resulted in inactivation of PTCH2 inhibitory activities. In contrast to wild type PTCH2, PTCH2-R719Q could not inhibit cell proliferation.

                Conclusion: PTCH2 (2157G>A), a novel missense mutation underlies NBCCS that results in the loss of PTCH2 inhibitory function in the Shh signalling pathway.

                • NBCCS
                • PTCH2
                • loss of function
                • missense mutation

                Statistics from Altmetric.com

                Request permissions

                If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.